Despite a slower Q2, Needham sees medtech market growing 7% in 2023 (NYSE:BSX)

Despite a slower Q2, Needham sees medtech market growing 7% in 2023 (NYSE:BSX)


Pulse trace and Stethoscope

enot-poloskun

Needham sees the medtech sector growing by 7% in 2023 versus 5.7% last year, despite slowed growth in Q2, helped by double-digit growth in certain cardiology categories.

The investment bank noted that medtech growth slowed slightly in Q2, expanding by only



Source link

https://ift.tt/4RfISdr
Next Post Previous Post
No Comment
Add Comment
comment url